Dr Kinan Mokbel

Dr Kinan Mokbel is a pharmacist, Programme Director for the MSc Leading Clinical Research Delivery, and Senior Lecturer in Postgraduate Education at the University of Exeter. Kinan is also an Honorary Professor (Visiting) at Brunel University London and Honorary Senior Research Fellow at the London Breast Institute, The Princess Grace Hospital, London. He brings more than twenty years of experience across pharmacy practice, clinical research and higher education, with an academic portfolio spanning clinical pharmacy, advanced clinical practice, pharmacology, clinical research delivery and precision medicine.

Kinan provides strategic academic leadership for the MSc Leading Clinical Research Delivery, with responsibility for programme development, curriculum enhancement, assessment, quality assurance and the student experience. His work focuses particularly on strengthening the clinical research workforce and supporting healthcare professionals to develop the knowledge and confidence required to lead and deliver high-quality research.

Alongside this programme leadership, Kinan is the Module Lead for core modules within both the MSc Clinical Pharmacy and MSc Advanced Clinical Practice programmes:

• Long-Term Condition Care (Respiratory, Endocrine, and Renal)
• Long-Term Condition Care (Cardiovascular)

Through these modules, he leads curriculum design, teaching, assessment and quality assurance, integrating contemporary evidence with clinical reasoning and patient-centred decision-making. He has introduced professionally aligned assessments, bespoke marking criteria and research-informed learning activities designed to improve clarity, consistency and the application of knowledge to practice.

Kinan is also the Pharmacology Strand Lead for the MSci Nursing programme, overseeing the progressive development of pharmacology teaching and assessment across all four years. His educational practice is grounded in his professional background as a pharmacist and in his research expertise in pharmacogenomics, medicines safety, clinical decision-making, adverse drug effects, cancer diagnosis, long COVID and clinical research methodology. A consistent theme across this work is the translation of research into safer prescribing and improved patient care.

Through his roles at Brunel University London and the London Breast Institute, The Princess Grace Hospital, London, Kinan works with multidisciplinary collaborators across universities, healthcare organisations and international research networks. In clinical research, Kinan is the primary patient contact and is responsible for coordinating the safe delivery of clinical assessments and treatments for the ERASE-LC study. He previously held a Postdoctoral Research Fellowship at the University of Exeter, contributing to the Spotting Cancer among Comorbidities (SPOCC) programme - an NIHR-funded project with University College London. His research focused on help-seeking behaviour and the early identification of cancer in patients with existing comorbidities.

Kinan is also the University of Exeter lead for NIHR INSIGHT. A distinctive part of Kinan’s academic contribution is supporting the development of future researchers. He supervises doctoral students, mentors postgraduate learners and has established publication-focused support that has helped students progress from taught programmes into peer-reviewed publication and doctoral study. His educational leadership is characterised by inclusive practice, high academic expectations and a strong commitment to widening participation.

Kinan welcomes collaboration with researchers, healthcare organisations and postgraduate students in clinical research delivery, clinical pharmacy, pharmacology, medicines safety, pharmacogenomics and health professions education.

Qualifications

• Master of Pharmacy
• Master of Science in Clinical Pharmacy
• Master of Science in Genomic Medicine
• PhD - Pharmacogenomics of Medically Important Adverse Drug Effects
• Learning & Teaching in Higher Education (LTHE)
• ASPIRE Higher Education Academy Associate Fellowship
• Fellow of the Higher Education Academy (FHEA)
• Senior Fellow of the Higher Education Academy (SFHEA)

Research projects

• ERASE – long COVID (Clinical feasibility study of the efficacy of Remdesivir for long COVID)
• LOCOMUS study (Long COVID related inflammatory processes. What is its association on bone, joints, and musculoskeletal microvascular haemodynamics?)
• SPOCC: SPOtting Cancer among Comorbidities.
• Evaluation of the Effectiveness of a Structured Nurse Burnout Reduction Program on Job Performance and Intention to Leave among Nurses
• Assessment of the Effectiveness of a Nurse-Led Triage Training Program on Triage Accuracy and Waiting Time in Emergency Departments
• Evaluation of the Effect of a Multimodal Hand Hygiene Intervention on Knowledge, Compliance, and Perceived Barriers among Intensive Care Unit Healthcare Workers
• The Effectiveness of a Structured Nursing Handover Protocol on Information Completeness, Medication Errors, and Patient Safety Incidents in the High-Risk Maternity Department

• Pharmacogenomics of Medically Important Adverse Drug Effects. Learn about genomic medicine and pharmacy practice.
• Assessing the prevalence of genotypes conferring risk of severe adverse drug reactions in participants of UK Biobank. Learn about Genomics for Pharmacy and its significance in pharmacy practice.
• Enacting cultural competence in primary care communication with Muslim patients: a mixed-methods study in south-west England and the role of collaboration with mosques
• Research Challenges among Academic Staff and Postgraduate Students in Healthcare Professions in the United Kingdom and Palestine

Research group links

• Exeter Collaboration for Academic Primary Care (APEx)
• ERASE – long COVID (Clinical feasibility study of the efficacy of Remdesivir for long COVID)

Research interests

• Genomic profiling for chemotherapy recommendations in breast and colorectal cancers.
• Prognostication tools in the context of adjuvant treatment of early breast cancer.
• Genetic testing in clinical practice.
• Pharmacogenomics of adverse drug effects.
• Spotting cancer among comorbidities and supporting clinical decision-making in patients with symptoms of cancer and pre-existing conditions
• Long COVID
• Safety of medicines in general practice and the role of community pharmacists in addressing adverse drug effects.
• Chemoprevention of breast and prostate cancers with vitamins and micronutrients.
• How Islamic cultural values shape health narratives in Muslim communities.

Conferences and invited presentations

The Third International Conference on Pharmaceutical Sciences (ICPSIII), 15-16 July 2026, Gaza Strip. Integrating Pharmacovigilance into Pharmacogenomics for Personalised Risk Management.

The Clinical Pharmacy Congress 8-9 May 2026, London, England. Malnutrition and Anaemia Among Children Aged 6–24 Months in Conflict-Affected Gaza: A Cross-Sectional Study with Implications for Clinical Pharmacy Support (Abstract).

The Clinical Pharmacy Congress 8-9 May 2026, London, England. Knowledge and Attitudes of Nurses toward Drugs Affecting Breastfeeding in Governmental Primary Health Care Clinics in Gaza Strip (Pending).

The Clinical Pharmacy Congress 9-10 May 2025, London, England. Expanding Pharmacy Services with Point-of-Care Testing for Strep A as a Model for Future Care - Driving Down Antibiotic Prescriptions from the Heart of the Community through Point-of-Care Testing. Author URL.

Annual Scientific Meeting of the Pharmacogenomics Global Research Network (PGRN) September 23-25, 2024 at the Ohio State University in Columbus, Ohio, USA. Atlas of Pharmacogenomic Variants Underpinning Adverse Drug Effects: Unveiling Critical Insights for Advancing Precision Medicine. Author URL.

The Clinical Pharmacy Congress 10-11 May 2024, London, England. The Impact of the COVID-19 Pandemic on Medication Prescribing Patterns in General Practice: A Retrospective Time-trend Analysis. Abstract.

The Clinical Pharmacy Congress North 3-4 November 2023, Manchester, England. A Nationwide Comparative Safety Study of Medicines Within the Therapeutic Class: A Novel Data Integration Approach Based on the Yellow Card Reporting Scheme and the English General Practice Prescription Data. Abstract.

The 7th International Congress of the European Society for Pharmacogenomics and Personalised Therapy (ESPT), October 25-27th, 2023, Copenhagen, Denmark. Pharmacogenomic Variants of Medically Important Adverse Effects Related to High-Risk Medicines in General Practice Can Not Be Replicated in UK Biobank. Abstract.

The 16th Annual Meeting of Korean Society of Medical Oncology & 2023 International Conference & 11th International FACO Conference, September 7th to 8th 2023, Seoul, Korea. Pharmacogenetics of Endocrine Therapy Associated Toxicities in Breast Cancer. Author URL.

The European Society of Human Genetics Conference, June 10–13th, 2023, Glasgow, Scotland, UK. The Majority of Pharmacogenomic Variants Associated with Adverse Drug Events When Taking Endocrine Therapies for Breast Cancer Can Not Be Replicated in UK Biobank Participants. Author URL.

The Association for Cancer Surgery Annual Scientific Conference and NCRI Cancer Conference 5th–8th November 2017 Liverpool, UK. A comparison of the performance of EndoPredict Clinical and NHS PREDICT in 120 patients treated for ER+ breast cancer. Author URL.

Manuscript(s) under consideration

• Clinical value of PPP2R4 and its protein complex in colorectal cancer
• FAM171A2 expression in colon cancer and its potential clinical value
• Contactin-1 in human colon cancer identifies patients with poor clinical outcome in the context of lymph node positivity and Dukes staging.
• Ageing, Breast Cancer Metastasis, and the Case for Targeting RAGE Through Lifestyle
• An open-label, clinical feasibility study of the efficacy of remdesivir for Long COVID – ERASE LC
• Patient-reported experiences and perceived changes following treatment with remdesivir for Long COVID – ERASE LC
• Holding the academic thread in Gaza: rethinking postgraduate supervision as continuity infrastructure during war
• When Supervision Becomes Academic Development Infrastructure: Sustaining Postgraduate Research Supervision in Gaza During War
• Research capacity challenges in health sciences education: a critical comparative review of the United Kingdom and Palestine
• Radiation protection knowledge, observed practice and panoramic dose-area product variation in dental radiography in Gaza: a cross-sectional study
• Interventions for improving the early detection of cancer in primary care patients with anxiety and/or depression: a systematic review and narrative synthesis.
• Medicines information support and breastfeeding counselling among primary care nurses in Gaza: a cross-sectional study
• Unmet services, financial burden, caregiver wellbeing and stress among families of children with disabilities in the Gaza Strip: a mixed-methods study
• Teaching the Sustainable Development Goals through clinical decision-making: A contemporary issues paper
• Access, Utilisation and Compliance with Family Planning Methods among Women in Gaza: A cross-sectional Study
• Pregnant Women’s Experience of Governmental Antenatal Care in the Gaza Strip: A Cross-Sectional Study of Satisfaction, Waiting Time, and Differences Across Clinics
• Nutritional Status and Associated Factors Among Children Aged 6-24 Months at a Primary Health Care Centre in Conflict-Affected Gaza
• Disability, fatigue and mental health in acute versus chronic spinal pain in the Gaza Strip: A comparative cross-sectional study
• Local diagnostic reference levels and optimisation priorities for paediatric oncology computed tomography in the Gaza Strip
• Making preconception care visible in primary care settings: a cross-sectional study of primigravida women in Gaza, Palestine
• Limited associations of MRI-derived lumbo-pelvic angles with lumbar discopathy and disability in adults with low back pain from the Gaza Strip: a cross-sectional study